Form 483

Douglas Manufacturing Limited Form 483, 2014-07-04

FDA issued a Form 483 to Douglas Manufacturing Limited on 2014-07-04 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Douglas Manufacturing Limited · Auckland, New Zealand · Issued July 4, 2014

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Jul 2014
21 CFR 211.68(b)

Computer control of master formula records

Cited by Michael H Tollon, Kim L Thomas Cruse

4 Jul 2014
21 CFR 211.160(b)(3)

Drug products-sampling procedures/specifications

Cited by Michael H Tollon, Kim L Thomas Cruse

4 Jul 2014
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Michael H Tollon, Kim L Thomas Cruse

4 Jul 2014
21 CFR 211.166(a)

Lack of written stability program

Cited by Michael H Tollon, Kim L Thomas Cruse

4 Jul 2014
21 CFR 211.194(c)

Testing and standardization of standards et. al.

Cited by Michael H Tollon, Kim L Thomas Cruse

Inspected site

DMDouglas Manufacturing LimitedAuckland, New Zealand

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(c)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere